Study Confirms Viraleze Antiviral Nasal Spray Provides Protection Against SARS-CoV-2 in Challenge Model
- Monday, August 23, 2021, 6:26
- PR Newswire
- Add a comment
MELBOURNE, Australia, Aug. 23, 2021 /PRNewswire/ — Melbourne biotech company Starpharma has announced the publication of new data demonstrating the capability of its Viraleze antiviral nasal spray to protect against SARS-CoV-2 in an animal challenge model of SARS-CoV-2 infection[1]….
About the Author
admin has written 20655 stories on this site.